|
1
|
Ho JH: An epidemiologic and clinical study
of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys.
4:182–198. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Feng XP, Yi H, Li MY, Li XH, Yi B, Zhang
PF, Li C, Peng F, Tang CE, Li JL, et al: Identification of
biomarkers for predicting nasopharyngeal carcinoma response to
radiotherapy by proteomics. Cancer Res. 70:3450–3462. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qu C, Liang Z, Huang J, Zhao R, Su C, Wang
S, Wang X, Zhang R, Lee MH and Yang H: MiR-205 determines the
radioresistance of human nasopharyngeal carcinoma by directly
targeting PTEN. Cell Cycle. 11:785–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Teo P, Yu P, Lee WY, Leung SF, Kwan WH, Yu
KH, Choi P and Johnson PJ: Significant prognosticators after
primary radiotherapy in 903 nondisseminated nasopharyngeal
carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol
Phys. 36:291–304. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DeNittis AS, Liu L, Rosenthal DI and
Machtay M: Nasopharyngeal carcinoma treated with external
radiotherapy, brachytherapy, and concurrent/adjuvant chemotherapy.
Am J Clin Oncol. 25:93–95. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee AW, Poon YF, Foo W, Law SC, Cheung FK,
Chan DK, Tung SY, Thaw M and Ho JH: Retrospective analysis of 5037
patients with nasopharyngeal carcinoma treated during 1976–1985:
Overall survival and patterns of failure. Int J Radiat Oncol Biol
Phys. 23:261–270. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leung SF, Teo PM, Shiu WW, Tsao SY and
Leung TW: Clinical features and management of distant metastases of
nasopharyngeal carcinoma. J Otolaryngol. 20:27–29. 1991.PubMed/NCBI
|
|
8
|
Blackwood RA and Ernst JD:
Characterization of Ca2(+)-dependent phospholipid binding, vesicle
aggregation and membrane fusion by annexins. Biochem J.
266:195–200. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo C, Liu S and Sun MZ: Potential role of
Anxa1 in cancer. Future Oncol. 9:1773–1793. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng GQ, Yi H, Li XH, Shi HY, Li C, Li MY,
Zhang PF, Feng XP, Wan XX, Qu JQ, et al: Identification of the
proteins related to p53-mediated radioresponse in nasopharyngeal
carcinoma by proteomic analysis. J Proteomics. 74:2723–2733. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeng GQ, Zhang PF, Deng X, Yu FL, Li C, Xu
Y, Yi H, Li MY, Hu R, Zuo JH, et al: Identification of novel
biomarkers for early detection of human lung squamous cell cancer
by quantitative proteomics. Mol Cell Proteomics. 11:M111.013946.
2012. View Article : Google Scholar
|
|
12
|
Tulalamba W and Janvilisri T:
Nasopharyngeal carcinoma signaling pathway: An update on molecular
biomarkers. Int J Cell Biol. 2012:5946812012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang JT, Ko JY and Hong RL: Recent
advances in the treatment of nasopharyngeal carcinoma. J Formos Med
Assoc. 103:496–510. 2004.PubMed/NCBI
|
|
14
|
Vignard J, Mirey G and Salles B:
Ionizing-radiation induced DNA double-strand breaks: A direct and
indirect lighting up. Radiother Oncol. 108:362–369. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng R, Yao Q, Du S, Ren C, Sun Q, Xu Z,
Lin X and Yuan Y: The status of p53 in cancer cells affects the
role of autophagy in tumor radiosensitisation. J BUON. 19:336–341.
2014.PubMed/NCBI
|
|
16
|
Swa HL, Blackstock WP, Lim LH and
Gunaratne J: Quantitative proteomics profiling of murine mammary
gland cells unravels impact of annexin-1 on DNA damage response,
cell adhesion and migration. Mol Cell Proteomics. 11:381–393. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia SH, Hu LP, Hu H, Ying WT, Xu X, Cai Y,
Han YL, Chen BS, Wei F, Qian XH, et al: Three isoforms of annexin I
are preferentially expressed in normal esophageal epithelia but
down-regulated in esophageal squamous cell carcinomas. Oncogene.
21:6641–6648. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang L, Yang X, Zhong LP, Zhou XJ, Pan
HY, Wei KJ, Li J, Chen WT and Zhang ZY: Decreased expression of
Annexin A1 correlates with pathologic differentiation grade in oral
squamous cell carcinoma. J Oral Pathol Med. 38:362–370. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng AL, Huang WG, Chen ZC, Peng F, Zhang
PF, Li MY, Li F, Li JL, Li C, Hong Y, et al: Identification of
novel nasopharyngeal carcinoma biomarkers by laser capture micro
dissection and proteomic analysis. Clin Cancer Res. 14:435–445.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu S, Meng Q, Hu H and Zhang M:
Correlation of ANXA1 expression with drug resistance and relapse in
bladder cancer. Int J Clin Exp Pathol. 7:5538–5548. 2014.PubMed/NCBI
|
|
21
|
Suo A, Zhang M, Yao Y, Zhang L, Huang C,
Nan K and Zhang W: Proteome analysis of the effects of sorafenib on
human hepatocellular carcinoma cell line HepG2. Med Oncol.
29:1827–1836. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He ZY, Wen H, Shi CB and Wang J:
Up-regulation of hnRNP A1, Ezrin, tubulin b-2C and Annexin A1 in
sentinel lymph nodes of colorectal cancer. World J Gastroenterol.
16:4670–4676. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Biaoxue R, Xiling J, Shuanying Y, Wei Z,
Xiguang C, Jinsui W and Min Z: Upregulation of Hsp90-beta and
annexin A1 correlates with poor survival and lymphatic metastasis
in lung cancer patients. J Exp Clin Cancer Res. 31:702012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bai XF, Ni XG, Zhao P, Liu SM, Wang HX,
Guo B, Zhou LP, Liu F, Zhang JS, Wang K, et al: Overexpression of
annexin 1 in pancreatic cancer and its clinical significance. World
J Gastroenterol. 10:1466–1470. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rondepierre F, Bouchon B, Papon J,
Bonnet-Duquennoy M, Kintossou R, Moins N, Maublant J, Madelmont JC,
D'Incan M and Degoul F: Proteomic studies of B16 lines: Involvement
of annexin A1 in melanoma dissemination. Biochim Biophys Acta.
1794:61–69. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hummerich L, Müller R, Hess J, Kokocinski
F, Hahn M, Fürstenberger G, Mauch C, Lichter P and Angel P:
Identification of novel tumour-associated genes differentially
expressed in the process of squamous cell cancer development.
Oncogene. 25:111–121. 2006.PubMed/NCBI
|
|
27
|
Voisin SN, Krakovska O, Matta A, DeSouza
LV, Romaschin AD, Colgan TJ and Siu KW: Identification of novel
molecular targets for endometrial cancer using a drill-down
LC-MS/MS approach with iTRAQ. PLoS One. 6:e163522011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
D'Acunto CW, Fontanella B, Rodriquez M,
Taddei M, Parente L and Petrella A: Histone deacetylase inhibitor
FR235222 sensitizes human prostate adenocarcinoma cells to
apoptosis through upregulation of annexin A1. Cancer Lett.
295:85–91. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rodrigo JP, García-Pedrero JM, Llorente
JL, Fresno MF, Allonca E, Suarez C and Hermsen M: Down-regulation
of annexin A1 and A2 protein expression in intestinal-type
sinonasal adenocarcinomas. Hum Pathol. 42:88–94. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu F, Wang Y, Zeng S, Fu X, Wang L and
Cao J: Involvement of annexin A1 in multidrug resistance of
K562/ADR cells identified by the proteomic study. OMICS.
13:467–476. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tanaka T, Munshi A, Brooks C, Liu J, Hobbs
ML and Meyn RE: Gefitinib radiosensitizes non-small cell lung
cancer cells by suppressing cellular DNA repair capacity. Clin
Cancer Res. 14:1266–1273. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ju X, Liang S, Zhu J, Ke G, Wen H and Wu
X: Extracellular matrix metalloproteinase inducer
(CD147/BSG/EMMPRIN)-induced radioresistance in cervical cancer by
regulating the percentage of the cells in the G2/m phase of the
cell cycle and the repair of DNA Double-strand Breaks (DSBs). Am J
Transl Res. 8:2498–2511. 2016.PubMed/NCBI
|
|
33
|
Zheng H, Wang S, Zhou P, Liu W and Ni F:
Effects of Ligustrazine on DNA damage and apoptosis induced by
irradiation. Environ Toxicol Pharmacol. 36:1197–1206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Özyurt H, Çevik Ö, Özgen Z, Özden AS,
Çadırcı S, Elmas MA, Ercan F, Gören MZ and Şener G: Quercetin
protects radiation-induced DNA damage and apoptosis in kidney and
bladder tissues of rats. Free Radic Res. 48:1247–1255. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jendrossek V: The intrinsic apoptosis
pathways as a target in anticancer therapy. Curr Pharm Biotechnol.
13:1426–1438. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dewey WC, Ling CC and Meyn RE:
Radiation-induced apoptosis: Relevance to radiotherapy. Int J
Radiat Oncol Biol Phys. 33:781–796. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang Y, Li XJ, Chen Z, Zhu XX, Wang J,
Zhang LB, Qiang L, Ma YJ, Li ZY, Guo QL and You QD: Wogonin induced
calreticulin/annexin A1 exposure dictates the immunogenicity of
cancer cells in a PERK/AKT dependent manner. PLoS One.
7:e508112012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Petrella A, Festa M, Ercolino SF, Zerilli
M, Stassi G, Solito E and Parente L: Induction of annexin-1 during
TRAIL-induced apoptosis in thyroid carcinoma cells. Cell Death
Differ. 12:1358–1360. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chang L, Graham PH, Hao J, Ni J, Bucci J,
Cozzi PJ, Kearsley JH and Li Y: PI3K/Akt/mTOR pathway inhibitors
enhance radiosensitivity in radioresistant prostate cancer cells
through inducing apoptosis, reducing autophagy, suppressing NHEJ
and HR repair pathways. Cell Death Dis. 5:e14372014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tell R, Heiden T, Granath F, Borg AL, Skog
S and Lewensohn R: Comparison between radiationinduced cell cycle
delay in lymphocytes and radiotherapy response in head and neck
cancer. Br J Cancer. 77:643–649. 1998. View Article : Google Scholar : PubMed/NCBI
|
